Ruby Pelingon

733 total citations
10 papers, 424 citations indexed

About

Ruby Pelingon is a scholar working on Molecular Biology, Molecular Medicine and Pharmacology. According to data from OpenAlex, Ruby Pelingon has authored 10 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Molecular Medicine and 2 papers in Pharmacology. Recurrent topics in Ruby Pelingon's work include Antibiotic Resistance in Bacteria (4 papers), Adenosine and Purinergic Signaling (2 papers) and Parasitic Infections and Diagnostics (2 papers). Ruby Pelingon is often cited by papers focused on Antibiotic Resistance in Bacteria (4 papers), Adenosine and Purinergic Signaling (2 papers) and Parasitic Infections and Diagnostics (2 papers). Ruby Pelingon collaborates with scholars based in Australia, United States and Ireland. Ruby Pelingon's co-authors include Matthew A. Cooper, Mark S. Butler, Mark A. T. Blaskovich, Alysha G. Elliott, Johnny X. Huang, Angela M. Kavanagh, Soumya Ramu, Wanida Phetsang, Bernd Becker and Alejandra Gallardo‐Godoy and has published in prestigious journals such as Brain, Analytical Biochemistry and Journal of Medicinal Chemistry.

In The Last Decade

Ruby Pelingon

9 papers receiving 413 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ruby Pelingon Australia	8	192	147	101	79	54	10	424
Amanda Miller United States	9	331 1.7×	310 2.1×	79 0.8×	56 0.7×	25 0.5×	11	591
Weyland Cheng China	12	214 1.1×	144 1.0×	56 0.6×	37 0.5×	64 1.2×	47	559
Kenji Namba Japan	10	161 0.8×	136 0.9×	70 0.7×	105 1.3×	66 1.2×	18	446
Micah J. Gliedt United States	5	146 0.8×	154 1.0×	104 1.0×	87 1.1×	38 0.7×	6	338
James Whiteaker United States	7	249 1.3×	329 2.2×	125 1.2×	86 1.1×	28 0.5×	10	550
Rachel L. Soon United States	12	134 0.7×	301 2.0×	168 1.7×	95 1.2×	23 0.4×	18	483
Marie-Thérèse Labro France	12	88 0.5×	65 0.4×	139 1.4×	115 1.5×	30 0.6×	20	512
Amy Kutschke United States	10	197 1.0×	150 1.0×	68 0.7×	45 0.6×	112 2.1×	13	463
Takaaki Akasaka Japan	9	115 0.6×	182 1.2×	118 1.2×	61 0.8×	10 0.2×	11	311
Monica Borgonovi Italy	10	97 0.5×	116 0.8×	181 1.8×	116 1.5×	32 0.6×	19	423

Countries citing papers authored by Ruby Pelingon

Since Specialization

Citations

This map shows the geographic impact of Ruby Pelingon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruby Pelingon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruby Pelingon more than expected).

Fields of papers citing papers by Ruby Pelingon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruby Pelingon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruby Pelingon. The network helps show where Ruby Pelingon may publish in the future.

Co-authorship network of co-authors of Ruby Pelingon

This figure shows the co-authorship network connecting the top 25 collaborators of Ruby Pelingon. A scholar is included among the top collaborators of Ruby Pelingon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruby Pelingon. Ruby Pelingon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Albornoz, Eduardo A., Karine Mardon, Rajiv Bhalla, et al.. (2025). PET-MRI biomarkers reveal efficacy of a novel NLRP3 inhibitor in Parkinson’s disease models. Brain.

Pelingon, Ruby, Cassandra L. Pegg, Lucía F. Zacchi, et al.. (2020). Glycoproteomic measurement of site-specific polysialylation. Analytical Biochemistry. 596. 113625–113625. 4 indexed citations

Gallardo‐Godoy, Alejandra, Karl A. Hansford, Craig Muldoon, et al.. (2019). Structure-Function Studies of Polymyxin B Lipononapeptides. Molecules. 24(3). 553–553. 31 indexed citations

Jarrad, Angie M., Ang Chee Wei, Anjan Debnath, et al.. (2018). Design, Synthesis, and Biological Evaluation of 2-Nitroimidazopyrazin-one/-es with Antitubercular and Antiparasitic Activity. Journal of Medicinal Chemistry. 61(24). 11349–11371. 20 indexed citations

Hill, James R., Rebecca C. Coll, Nancy Sue, et al.. (2017). Sulfonylureas as Concomitant Insulin Secretagogues and NLRP3 Inflammasome Inhibitors. ChemMedChem. 12(17). 1449–1457. 49 indexed citations

Phetsang, Wanida, Ruby Pelingon, Mark S. Butler, et al.. (2016). Fluorescent Trimethoprim Conjugate Probes To Assess Drug Accumulation in Wild Type and Mutant Escherichia coli. ACS Infectious Diseases. 2(10). 688–701. 45 indexed citations

Jarrad, Angie M., Anjan Debnath, Yukiko Miyamoto, et al.. (2016). Nitroimidazole carboxamides as antiparasitic agents targeting Giardia lamblia, Entamoeba histolytica and Trichomonas vaginalis. European Journal of Medicinal Chemistry. 120. 353–362. 49 indexed citations

Salla, Manohar, Mark S. Butler, Ruby Pelingon, et al.. (2016). Identification, Synthesis, and Biological Evaluation of the Major Human Metabolite of NLRP3 Inflammasome Inhibitor MCC950. ACS Medicinal Chemistry Letters. 7(12). 1034–1038. 40 indexed citations

Gallardo‐Godoy, Alejandra, Craig Muldoon, Bernd Becker, et al.. (2016). Activity and Predicted Nephrotoxicity of Synthetic Antibiotics Based on Polymyxin B. Journal of Medicinal Chemistry. 59(3). 1068–1077. 98 indexed citations

10.

Huang, Johnny X., Mark A. T. Blaskovich, Ruby Pelingon, et al.. (2015). Mucin Binding Reduces Colistin Antimicrobial Activity. Antimicrobial Agents and Chemotherapy. 59(10). 5925–5931. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact